NICE technology appraisal guidance
Issued: April 2009
TA170
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta170
7 Related NICE guidance
-
Dabigatran etexilate for the prevention of venous thromboembolim after hip or knee replacement surgery in adults. NICE technology appraisal guidance 157 (2008).
-
Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. NICE clinical guideline 46 (2007). [Replaced by NICE clinical guideline 92]